(MEVPRO-2) 一项评估PF-06821497（美罗美司他）联合恩扎卢胺治疗转移性去势抵抗性前列腺癌的3期随机、双盲、安慰剂对照研究
Principal Investigator (PI)
Clinical Trials.gov ID
Key Eligibility
Protocol #
SPONSOR
